Inventor · disambiguated record
Javier De Vicente Fidalgo
Also filed as: DE VICENTE FIDALGO JAVIER
29 granted patents·25 pending applications·85 citations·filing 2010–2025
95Inventor score
Files withDENALI THERAPEUTICS INC47NICO THERAPEUTICS INC3DE VICENTE FIDALGO JAVIER2HOFFMANN LA ROCHE1TENVIE THERAPEUTICS INC1
Top patents by PatentIndex Score
54 records- 0197US11111235B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·7 cites·26 claims
- 0297US9815850B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·36 cites·41 claims
- 0396US9932325B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Apr 3, 2018·16 cites·30 claims
- 0491US11306077B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Apr 19, 2022·2 cites·47 claims
- 0590US11591316B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·1 cites·20 claims
- 0690US10590114B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 17, 2020·5 cites·27 claims
- 0789US2025034119A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0886US10604535B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2020·3 cites·18 claims
- 0986US10131676B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 20, 2018·3 cites·33 claims
- 1085US12358928B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·8 claims
- 1185US11834439B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2023·Granted Dec 5, 2023·0 cites·19 claims
- 1284US2025388601A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1383US11203600B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 21, 2021·2 cites·24 claims
- 1480US11236100B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·1 cites·30 claims
- 1580US2025011338A1Kinase Inhibitors and Uses ThereofDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1679US2024140919A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1776US11028080B2Substituted pyrimidines as LRKK2 inhibitorsDENALI THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·53 claims
- 1876US2023250072A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1975US11851440B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·0 cites·18 claims
- 2075US2025122159A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2174US8618103B2Inhibitors of JAKDE VICENTE FIDALGO JAVIER·Filed 2010·Granted Dec 31, 2013·4 cites·27 claims
- 2273US12139478B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Nov 12, 2024·1 cites·57 claims
- 2373US2023043400A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2472US2024025915A1Solid forms of 4-(3,3-difluoro-2,2-dimethyl-propanoyl)-3,5-dihydro-2h-pyrido[3,4-f][1,4]oxazepine-9-carbonitrileDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2571US8487103B2Quinoline inhibitors of hepatitis C virus polymeraseDE VICENTE FIDALGO JAVIER·Filed 2011·Granted Jul 16, 2013·2 cites·6 claims
- 2669US12180211B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 31, 2024·0 cites·5 claims
- 2769US12129263B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2021·Granted Oct 29, 2024·0 cites·19 claims
- 2869US9469644B2Inhibitors of Bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2014·Granted Oct 18, 2016·1 cites·17 claims
- 2969US2020317691A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3068US11958840B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·0 cites·45 claims
- 3168US2022153728A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3267US11851433B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·0 cites·17 claims
- 3367US11840529B2Substituted pyrimidines as LRKK2 inhibitorsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·38 claims
- 3467US2022119371A1Compound, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3566US2024317776A1Solid forms of 4-(3,3-difluoro-2,2-dimethyl-propanoyl)-3,5-dihydro-2h-pyrido[3,4-f][1,4]oxazepine-9-carbonitrileDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3665US11072618B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2019·Granted Jul 27, 2021·0 cites·17 claims
- 3765US2025388595A1Modulators of eukaryotic initiation factor 2b, compositions and methodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3864US2021130308A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3964US2017362206A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4061US2025361234A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4160US12091392B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2020·Granted Sep 17, 2024·0 cites·9 claims
- 4259US2025171462A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4359US2025145592A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4459US2025197399A1Compounds, compositions, and methodsTENVIE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4558US12358896B2LRRK2 inhibitors and methods of making and using thereofDENALI THERAPEUTICS INC·Filed 2020·Granted Jul 15, 2025·0 cites·18 claims
- 4658US2024254132A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4757US2020157081A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4855US11174262B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2019·Granted Nov 16, 2021·0 cites·16 claims
- 4954US11214565B2Compound, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2016·Granted Jan 4, 2022·0 cites·15 claims
- 5054US2023357162A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →